The coronavirus is a terrible handful across the country. The number of victims is increasing day by day. In this situation, the government of the country is advising to follow the rules of Corona Vaccination and Corona. Corona (Covid-19) new strains are raising new thoughts in him.
Corona's Indian and British strains have raised fears around the world. One of the reasons for this is that many experts claim that the corona vaccine is not effective on the Indian and British corona strains. In a report a few days ago, the World Health Organization (WHO) also claimed that vaccines like Pfizer and Modern were unable to affect these two strains. Covaxin made by India Biotech is shining a light of hope in these difficult times.
 |
| Check out the latest information about Covid 19 on Twitter |
 |
| Check out the latest information about Covid 19 on Twitter |
Covacin, developed by India Biotech and ICMR, is capable of counteracting both species of coronavirus found in Britain and India. On Sunday, pharmaceutical company India Biotech made such a demand. The species of coronavirus that was found in Britain was named B116, on the other hand B1617 was responsible for spreading the disease in India. There is another species of this virus called D614G. Suchitra Ella, Joint Managing Director, Bharat Biotech, shared a report in the medical journal 'Clinical Infectious Diseases' on Twitter.
The species spread throughout the world, including Europe. According to India Biotech, the efficacy rate on B1617 species is slightly lower than that of covacin on the D714G species of coronavirus. But much more than expected, according to the pharmaceutical company. Recently, Anthony Fossio, chief health adviser to US President Joe Biden, said that the covacin B1617, a coronavirus made in India, is capable of counteracting a double mutant species.
0 Comments